Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2024-12-23 M&A Activity
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Hermes Pharma d.o.o. - Accordo vincolante per l'acquisto del 100%
M&A Activity Classification · 98% confidence The document is titled 'COMUNICATO STAMPA' (Press Release) and is classified as 'Informazione Regolamentata' (Regulated Information) on Euronext Growth Milan. The subject ('Oggetto') is an agreement for the acquisition of 100% of Hermes Pharma D.o.o. This type of announcement, detailing a significant corporate transaction (M&A activity), is typically released via a press release format to inform the market immediately. Since it is a specific announcement about a merger/acquisition proposal, it fits the 'M&A Activity' category (TAR). It is not a full financial report (10-K or IR), nor is it a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the substantive details of the transaction itself.
2024-12-23 Italian
Avviso di convocazione Assemblea azionisti
AGM Information Classification · 99% confidence The document is titled "Avviso di convocazione Assemblea azionisti" (Notice of convocation of Shareholders' Meeting) and explicitly states that the documentation, including the explanatory report, is made available to the public on the company website and Borsa Italiana website, and the notice itself is published in the newspaper. The core content details the date, time, agenda (Ordinary and Extraordinary), and procedures for attending the meeting (exclusively via designated representative). This structure—announcing a meeting and referencing the availability of detailed documentation—is characteristic of a notice related to a shareholder meeting. The most specific category for materials shared during or related to a General Meeting is AGM-R (AGM Information), although this is technically the notice *for* the meeting, which often precedes the AGM itself. However, the agenda items (authorization for own share purchase, modification of bylaws) are typical AGM topics. Since the document is an official notice of a meeting and its associated documentation, and it is not the proxy statement (DEF 14A/PSI) itself, nor the voting results (DVA), the closest fit among the provided options is AGM-R, as it directly pertains to the Annual General Meeting process. Given the document is a formal notice of convocation, it is closely related to AGM materials. If 'Notice of Meeting' were an option, it would be preferred, but AGM-R is the best fit for meeting-related announcements.
2024-12-12 Italian
Cda convoca Assemblea ordinaria e straordinaria
AGM Information Classification · 97% confidence The document is a formal announcement ('COMUNICATO STAMPA') from Svas Biosana S.p.A. regarding the decision by the Board of Directors ('Consiglio di Amministrazione') to convene an Ordinary and Extraordinary Shareholders' Meeting ('Assemblea ordinaria e straordinaria degli Azionisti') on December 27, 2024. The agenda items include authorizing the purchase and disposal of treasury shares ('Autorizzazione all'acquisto e alla disposizione di azioni proprie') and modifying Article 16 of the Bylaws. This type of announcement, which calls for a shareholder meeting and details the proposals to be voted upon, is characteristic of materials related to corporate governance and shareholder voting procedures. Since the core purpose is to announce the meeting and the proposals therein, it strongly aligns with the scope of a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. Although it mentions share repurchase (POS topic), the document's primary function is the meeting convocation itself.
2024-12-11 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during the period from October 28, 2024, to November 1, 2024. The subject line explicitly states "Acquisto azioni proprie" (Purchase of own shares). This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance), which is classified as 'POS'. Although it is a weekly report, the core subject matter is the transaction itself, not a general regulatory announcement (RNS) or a report publication announcement (RPA), as it contains the detailed transaction data.
2024-11-01 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and details the number of shares the company (Svas Biosana S.p.A.) purchased during the period from October 21, 2024, to October 25, 2024. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2024-10-25 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during a specific week (October 14 to October 18, 2024) as part of an authorized share buyback program. This activity, the repurchase of company stock, directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2024-10-18 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.